[go: up one dir, main page]

MX2014015488A - Nalmefeno para reducir el consumo de alcohol en poblaciones especificas. - Google Patents

Nalmefeno para reducir el consumo de alcohol en poblaciones especificas.

Info

Publication number
MX2014015488A
MX2014015488A MX2014015488A MX2014015488A MX2014015488A MX 2014015488 A MX2014015488 A MX 2014015488A MX 2014015488 A MX2014015488 A MX 2014015488A MX 2014015488 A MX2014015488 A MX 2014015488A MX 2014015488 A MX2014015488 A MX 2014015488A
Authority
MX
Mexico
Prior art keywords
nalmefene
reduction
alcohol consumption
specific target
target populations
Prior art date
Application number
MX2014015488A
Other languages
English (en)
Other versions
MX371373B (es
Inventor
Lars Torup
Afsaneh Abbariki
Anna Bladström
Christine Persson
Didier Meulien
Per Sørensen
Thomas Jon Jensen
Jette Buch Østergaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014015488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MX2014015488A publication Critical patent/MX2014015488A/es
Publication of MX371373B publication Critical patent/MX371373B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a nalmefeno para su uso en la reducción del consumo de alcohol en un paciente con dependencia del alcohol que presenta un nivel de riesgo de beber (DRL, por sus siglas en inglés) alto. La presente invención también se refiere a nalmefeno para su uso en la reducción del consumo de alcohol en un paciente con dependencia del alcohol que mantiene un DRL alto después de un periodo de observación tras una evaluación inicial.
MX2014015488A 2012-06-27 2013-06-27 Nalmefeno para reducir el consumo de alcohol en poblaciones especificas. MX371373B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15
PCT/EP2013/063461 WO2014001427A1 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations

Publications (2)

Publication Number Publication Date
MX2014015488A true MX2014015488A (es) 2015-03-06
MX371373B MX371373B (es) 2020-01-28

Family

ID=48703496

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014015488A MX371373B (es) 2012-06-27 2013-06-27 Nalmefeno para reducir el consumo de alcohol en poblaciones especificas.

Country Status (35)

Country Link
US (4) US20140005217A1 (es)
EP (5) EP2866808B1 (es)
JP (3) JP6258933B2 (es)
KR (1) KR20150023396A (es)
CN (1) CN104411313A (es)
AU (1) AU2013283281B2 (es)
BR (1) BR112014032555A2 (es)
CA (1) CA2874703C (es)
CL (1) CL2014003484A1 (es)
CO (1) CO7160087A2 (es)
CY (3) CY1118579T1 (es)
DK (3) DK2866808T3 (es)
EA (1) EA029908B1 (es)
ES (4) ES2950492T3 (es)
FI (1) FI3345604T3 (es)
HK (1) HK1255683A1 (es)
HR (4) HRP20250329T1 (es)
HU (4) HUE031110T2 (es)
IL (1) IL236035B (es)
LT (3) LT3138564T (es)
ME (2) ME02587B (es)
MX (1) MX371373B (es)
MY (1) MY166914A (es)
NZ (1) NZ702191A (es)
PH (1) PH12014502798A1 (es)
PL (4) PL3345604T3 (es)
PT (3) PT2866808T (es)
RS (2) RS55456B1 (es)
RU (1) RU2665373C2 (es)
SG (1) SG11201408704WA (es)
SI (3) SI3138564T1 (es)
SM (3) SMT201600471T1 (es)
UA (1) UA114199C2 (es)
WO (1) WO2014001427A1 (es)
ZA (1) ZA201409525B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
JP6419780B2 (ja) * 2013-04-17 2018-11-07 ハー・ルンドベック・アクチエゼルスカベット 睡眠障害患者の治療のためのナルメフェン
BR112016024510A2 (pt) 2014-04-22 2017-08-15 H Lundbeck As ?medicamento, uso de brexpiprazol ou de um sal farmaceuticamente aceitável do mesmo, métodos para prevenção ou tratamento de um transtorno relacionado com substância e para produção de uma composição farmacêutica, composição farmacêutica, e, kit?
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
US20030153590A1 (en) * 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
EA019331B1 (ru) 2009-05-25 2014-02-28 Х. Лундбекк А/С Получение налмефена гидрохлорида из налтрексона
MX2013005009A (es) 2010-11-05 2013-08-01 Lundbeck & Co As H Metodo para la elaboracion de naltrexona.
JP5738470B2 (ja) 2011-03-31 2015-06-24 イムネクス ファーマ イラチュ サナイ ヴェ ティジャレット ア．シェ．Ｉｍｕｎｅｋｓ Ｆａｒｍａ Ｉｌａｃ Ｓａｎａｙｉ Ｖｅ Ｔｉｃａｒｅｔ Ａ．Ｓ． オピオイド拮抗体組成物、および強皮症の治療のためのその使用
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
JP2018039810A (ja) 2018-03-15
CY1126140T1 (el) 2023-11-15
JP6857684B2 (ja) 2021-04-14
RS57046B1 (sr) 2018-05-31
SMT201600471T1 (it) 2017-03-08
ES2663532T3 (es) 2018-04-13
CA2874703A1 (en) 2014-01-03
LT3138564T (lt) 2018-04-10
EP4223296B1 (en) 2025-01-29
MY166914A (en) 2018-07-24
DK3345604T3 (da) 2023-07-24
HUE031110T2 (en) 2017-06-28
DK2866808T3 (en) 2017-01-16
SMT201600471B (it) 2017-03-08
CY1120097T1 (el) 2018-12-12
JP6258933B2 (ja) 2018-01-10
EP2866808B1 (en) 2016-11-02
SG11201408704WA (en) 2015-01-29
ME02587B (me) 2017-06-20
MX371373B (es) 2020-01-28
HRP20230762T8 (hr) 2024-01-05
LT2866808T (lt) 2017-01-10
CA2874703C (en) 2022-08-23
ES3014068T3 (en) 2025-04-16
NZ702191A (en) 2017-06-30
PT3138564T (pt) 2018-04-03
CL2014003484A1 (es) 2015-02-27
CO7160087A2 (es) 2015-01-15
SMT201800164T1 (it) 2018-07-17
US10034874B2 (en) 2018-07-31
AU2013283281A1 (en) 2014-12-11
RU2014151156A (ru) 2016-08-20
PT2866808T (pt) 2017-01-03
SI3138564T1 (en) 2018-04-30
EP4541421A3 (en) 2025-06-18
EA029908B1 (ru) 2018-05-31
PH12014502798A1 (en) 2015-02-09
US20160375007A1 (en) 2016-12-29
HUE036272T2 (hu) 2018-06-28
HRP20161717T1 (hr) 2017-02-10
EP4223296A3 (en) 2023-09-27
EP3138564B1 (en) 2018-01-31
RS55456B1 (sr) 2017-04-28
PL2866808T3 (pl) 2017-04-28
EP4223296A2 (en) 2023-08-09
EP4541421A2 (en) 2025-04-23
PL3138564T3 (pl) 2018-06-29
SI3345604T1 (sl) 2023-08-31
LT3345604T (lt) 2023-08-10
WO2014001427A1 (en) 2014-01-03
ZA201409525B (en) 2016-08-31
BR112014032555A2 (pt) 2017-06-27
UA114199C2 (uk) 2017-05-10
US20180028526A1 (en) 2018-02-01
PL4223296T3 (pl) 2025-04-14
US9642849B2 (en) 2017-05-09
JP2019163275A (ja) 2019-09-26
ES2609122T3 (es) 2017-04-18
US20140005216A1 (en) 2014-01-02
AU2013283281B2 (en) 2017-04-20
CN104411313A (zh) 2015-03-11
HRP20180363T1 (hr) 2018-04-20
EA201492152A1 (ru) 2015-11-30
JP2015521647A (ja) 2015-07-30
EP2866808A1 (en) 2015-05-06
HRP20230762T1 (hr) 2023-10-13
HRP20250329T1 (hr) 2025-05-09
ES2950492T3 (es) 2023-10-10
HK1208185A1 (en) 2016-02-26
DK3138564T3 (en) 2018-03-26
CY1118579T1 (el) 2017-07-12
EP3345604B1 (en) 2023-06-07
ME03030B (me) 2018-10-20
KR20150023396A (ko) 2015-03-05
PL3345604T3 (pl) 2023-08-28
IL236035B (en) 2018-12-31
HK1255683A1 (en) 2019-08-23
HUE070621T2 (hu) 2025-06-28
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
EP3138564A1 (en) 2017-03-08
US20140005217A1 (en) 2014-01-02
PT3345604T (pt) 2023-07-17
EP4223296C0 (en) 2025-01-29
IL236035A0 (en) 2015-01-29
FI3345604T3 (fi) 2023-07-28
HUE063313T2 (hu) 2024-01-28
EP3345604A1 (en) 2018-07-11

Similar Documents

Publication Publication Date Title
AU342950S (en) Utility pump
AU342351S (en) Automobile
AU338331S (en) Handle
AU341123S (en) Oil pan
CY1126140T1 (el) Ναλμεφενη για τη μειωση της καταναλωσεως αλκοολης σε συγκεκριμενους πληθυσμους στοχους
AU342936S (en) Insole
GB201102108D0 (en) Diagnostic method
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU338318S (en) Latch
MX2013005759A (es) Metodos para detectar bajo grado de inflamacion.
AU338332S (en) Handle
AU344993S (en) Toilet pan
CA144989S (en) Adapter for firearms
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия
AU349260S (en) Refill for device
AU341442S (en) Soles
AU341441S (en) Soles
AU340248S (en) Soles
AU340249S (en) Soles
UA72478U (ru) Применение полентара как средства фригопротекторного действия
AU341341S (en) Shoes

Legal Events

Date Code Title Description
FG Grant or registration